Rheumatoid Arthritis Clinical Trials in New York

Showing 541-560 of 1,972 trials

A Study to Compare Nighttime Aligners to Daytime Aligners

NCT06539676

The purpose of this research study is to see if Nighttime Aligners (worn 10-12 hours per day or night) are effective and safe for tooth movement and if so, how they compare with the standard Daytime aligners (worn 20-22 hours per day), in adults and children from 12 years of age and older. It will investigate the efficacy and performance of the treatments, as well as the safety of the investigational device and comparator. The main objectives are: * Comparison between the two groups concerning actual vs planned tooth movements (measured by changes in tooth position) * Comparison between the two groups concerning the incidence of device or dental related AEs. * Overall dentist and participant satisfaction with the treatment. Participants will: * Be given orthodontic aligner therapy with the Daytime (20-22h/day) or Nighttime (10-12h/day) Aligners (randomly assigned) * Attend approximately 5 study during approximately 8-10 months

Teeth StraighteningAligner TherapyOrthodontic Aligner

Dentsply Sirona Implants and Consumables7 participantsStarted Sep 2024

Redondo Beach, California, United States • Miami Beach, Florida, United States • Towson, Maryland, United States +9 more locations

RECRUITINGPHASE3< 1 mile

The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global)

NCT06520345

The purpose of this study is to evaluate the efficacy and safety of 177Lu-TLX591 in patients with metastatic castration-resistant prostate cancer who have progressed following treatment with Androgen Receptor Pathway Inhibitor Treatment

Metastatic Castration-resistant Prostate Cancer

Telix Pharmaceuticals (Innovations) Pty Limited430 participantsStarted Jul 2024

Orange, California, United States • Miami, Florida, United States • Glen Burnie, Maryland, United States +12 more locations

A Study to Compare Nighttime Aligners to Daytime Aligners

The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global)

Rheumatoid Arthritis Trials in Other Cities

Abemaciclib (LY2835219) in Patients With Recurrent Primary Brain Tumors

Study of Cemiplimab Combined With Dabrafenib and Trametinib in People With Anaplastic Thyroid Cancer

Vaginal Ecosystem and Network in the United States Study

Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules

Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 Mutations

Topotecan by Intracerebral Clysis for Recurrent Primary Malignant Brain Tumors

Impact of Cyanoacrylate Glue on PICC Line Dressing Care

Perceptual Adaptation Following Cochlear Implantation (Aim 3a)

An Open-Label Treatment With Randomization Observation, Investigator-Initiated Study, on the Duration and Efficacy of Jornay PM (Methylphenidate Hydrochloride Extended-Release Capsules) on Adult ADHD Symptoms and Executive Function and Emotional Regulation Throughout the Day Into Early Evening

Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis

The GUARD Trial - Part 1: A Phase 3 Clinical Trial for Prevention of Proliferative Vitreoretinopathy

A Masked, Placebo-controlled Study to Assess Iptacopan in Age-related Macular Degeneration

Step 1: Be Aware, Anxiety Prevention Intervention

9-ING-41 in Pediatric Patients With Refractory Malignancies.

Comparing Different Types of Physical Therapy for Treating People With a Meniscal Tear and Osteoarthritis

Implementation of Innovative Treatment for Moral Injury Syndrome: A Hybrid Type 2 Study

A Study Evaluating Safety, Tolerability, and Clinical Activity of Forimtamig-Based Treatment Combinations in Participants With Relapsed or Refractory Multiple Myeloma

LSALT Peptide vs. Placebo to Prevent ARDS and Acute Kidney Injury in Patients Infected With SARS-CoV-2 (COVID-19)

Other Conditions in New York